Schedule 13G ownership disclosure

Benitec Biopharma Inc

Security class unavailable · CUSIP: 08205P209

Event date: 2023-08-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-093916
Form type
SC 13G
Filer
Benitec Biopharma Inc.
CIK
CIK 1808898
Filed
Aug 21, 2023
Reporting period
Aug 11, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub